Journal
CELL
Volume 135, Issue 3, Pages 449-461Publisher
CELL PRESS
DOI: 10.1016/j.cell.2008.08.035
Keywords
-
Categories
Funding
- National Institutes of Health [RO1HD048769-01A1]
- Harvard Stem Cell Institute
- Dutch Cancer Society (Koningin Wilhelmina Fonds)
Ask authors/readers for more resources
Pluripotent stem cell lines can be derived from blastocyst embryos, which yield embryonic stem cell lines (ES cells), as well as the postimplantation epiblast, which gives rise to epiblast stem cell lines (EpiSCs). Remarkably, ES cells and EpiSCs display profound differences in the combination of growth factors that maintain their pluripotent state. Molecular and functional differences between these two stem cell types demonstrate that the tissue of origin and/or the growth factor milieu may be important determinants of the stem cell identity. We explored how developmental stage of the tissue of origin and culture growth factor conditions affect the stem cell pluripotent state. Our findings indicate that novel stem cell lines, with unique functional and molecular properties, can be generated from murine blastocyst embryos. We demonstrate that the culture growth factor environment and cell-cell interaction play a critical role in defining several unique and stable stem cell ground states.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available